Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000147646 | SCV000195095 | uncertain significance | Developmental and epileptic encephalopathy, 5 | 2013-03-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000713521 | SCV000521699 | likely benign | not provided | 2021-10-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001088259 | SCV000633796 | benign | Early infantile epileptic encephalopathy with suppression bursts | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000713521 | SCV000844142 | benign | not provided | 2018-08-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312981 | SCV000848852 | likely benign | Inborn genetic diseases | 2017-01-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000420949 | SCV000860313 | likely benign | not specified | 2018-03-29 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000147646 | SCV002056603 | benign | Developmental and epileptic encephalopathy, 5 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004737228 | SCV005352468 | likely benign | SPTAN1-related disorder | 2024-06-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |